Recombinant Human IL12/15-PDL1B Oncolytic HSV-1 Injection (Vero Cell)) Clinical Trials
3 recruitingDrug
Phase 12Phase 22
Showing 1–3 of 3 trials
Recruiting
Phase 2
Clinical Study of VG161 in Advanced Intrahepatic Cholangiocarcinoma
Advanced Intrahepatic Cholangiocarcinoma
CNBG-Virogin Biotech (Shanghai) Ltd.33 enrolled1 locationNCT06746480
Recruiting
Phase 1
Clinical Study of VG161 in Subjects with Advanced Primary Liver Cancer
Primary Liver Cancer
CNBG-Virogin Biotech (Shanghai) Ltd.44 enrolled1 locationNCT04806464
Recruiting
Phase 1Phase 2
Clinical Study of VG161 Combined With Nivolumab Injection in Patients With Advanced Metastatic Gastric Cancer
Metastatic Gastric Cancer
CNBG-Virogin Biotech (Shanghai) Ltd.43 enrolled1 locationNCT06008925